Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection

NCT04413838 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Obesity, COVID-19 Infection

Interventions

DRUG: NIVOLUMAB
OTHER: Routine standard of care

Sponsor

Hospices Civils de Lyon